Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02139839Phase 1Completed
Phase 1, randomised, double-blind trial (2 arms), sponsored by Kimberly-Clark. Primary endpoint: Change from baseline Nugent Score at Day 40. Started Sep 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02139839.